-
US House targets data centers as midterm backlash grows
-
WTA Finals moved to Charlotte from 2027
-
French ex-minister Dati goes on trial in Renault-Nissan corruption case
-
Almost 8,000 excess deaths in France's scorched summer: statistics
-
'Being Heumann' captures joy in fight for disability rights
-
Ex-president's lengthy war crimes sentence shocks Kosovo
-
Retired great Nadal to play in exhibition matches
-
US House faces test on sweeping Russia sanctions bill
-
IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan
-
British PM says to make 'difficult decisions' as inflation rises
-
Watts, Pitt, Cruz to light up Spain's top film festival
-
TotalEnergies pumps up controversy in France with cut-price gas
-
Sweden expels Iran embassy employee over anti-Jewish threats
-
Global fuel price demos: a round-up
-
Toogood Gold's Table Mountain Sits in the Shadow of a Nevada Gold Rush
-
Leverate Launches MCP for Traders to Connect AI Assistants With Trading Platforms
-
MEXC July–August Security Report: 38.66M USDT in Risk Funds Intercepted, Futures Insurance Fund Hits 792M USDT
-
MEXC Launches $1M "Discover Your Wall Street DNA" Campaign to Help Traders Find Their Market Fit
-
'Breathing toxin every day': Indonesians choked by haze feel helpless
-
Emporio Armani names Dario Vitale new creative director
-
Stocks edge higher ahead of US Fed rate call
-
Maresca defends VAR officials after Man City benefit from error
-
Philippines ex-leader Duterte makes first in-person ICC appearance
-
Courts jails LGBTQ activists as Turkey crackdown widens
-
2027 Formula One calendar includes Monaco sprint race
-
French court to hear Depardieu's appeal against rape trial order: sources
-
Palestinians are the real victims, Thunberg tells Ed Sheeran
-
The German state premier hoping to halt far-right surge
-
Hashim Thaci: From 'George Washington of Kosovo' to Hague convict
-
Lebanon wants Israel security deal as prelude to peace: president to AFP
-
Amnesty says Iran committed 'crimes against humanity' in crackdown on 2022 protests
-
England's Brook keen to learn from 'hero' Pietersen after stunning ton
-
EU to ban social media for under 13s, curb access until 15
-
Saudi says Houthis target Mecca, warns of 'red line'
-
Philippines ex-leader Duterte makes first appearance at ICC
-
Phillippines ex-leader Duterte makes first appearance at ICC
-
EU chief pitches 'associate member' status for Canada
-
Lebanon wants Israel security deal, Hezbollah disarmament without confrontation: president to AFP
-
English village votes to 'secede' from UK over asylum centre plan
-
BASIS.pro Expands On-Chain Infrastructure with XDC Network Partnership and Zypher DAO as Auto Earn Goes Live
-
Wildfires push endangered Sumatran elephants to brink: Indonesian NGO
-
Samson relishing battle with teen star Sooryavanshi for India spot
-
Stocks head higher as traders prepare for Fed decision
-
Pickle-flavoured tart? AI inspires Japan's convenience stores
-
English village votes to 'secede' from UK over asylum centre
-
Macau holds first closed-door national security trial
-
Hong Kong unveils plan to align economy with China's goals
-
Bank of Japan set to raise rates under pressure from inflation, US
-
Brazilian voters the latest to eye Bukele security model with envy
-
Zverev, Shelton back on court for Davis Cup qualifiers
Olympus CEO resigns over alleged illegal drugs purchase
The German CEO of major Japanese optical equipment manufacturer Olympus has stepped down after allegedly buying illegal drugs, the company said on Monday.
Stefan Kaufmann became chief executive officer in April 2023, having served as a board member since 2019. He first joined the European arm of Olympus in 2003.
Olympus shares plunged six percent in morning trade as the company apologised in a statement "for the concern this has caused to our shareholders, customers and all stakeholders".
"Upon receiving an allegation that Mr Stefan Kaufmann had purchased illegal drugs, Olympus, in consultation with outside legal counsel, immediately investigated the facts, made a report to the investigative authorities, and cooperated fully with their investigation," it said.
The company's board of directors then "unanimously determined" that Kaufmann "likely engaged in behaviours that were inconsistent with our global code of conduct".
Kaufmann, who is reportedly the company's second non-Japanese president, was asked to offer his resignation which the board then accepted, Olympus added.
Olympus said in 2020 it was selling its struggling camera division to focus on medical equipment. It had been in the camera business since 1936, but struggled along with industry rivals after the advent of smartphones.
The storied company has seen success in the medical equipment field, and controls much of the global endoscope market.
Olympus chairman Yasuo Takeuchi will stand in as CEO "for the time being" while the board's nominating committee considers "all options for a successor", the company said.
G.Frei--VB